Arteriovenous Malformation Market Forecast: Size, Share, and Outlook to 2034
The Arteriovenous Malformation Market is forecasted to grow steadily due to increasing AVM prevalence, technological advancements, and higher adoption of minimally invasive therapies.
Emerging markets in Asia-Pacific and Latin America are likely to see substantial growth due to improving healthcare infrastructure, awareness programs, and government initiatives supporting AVM management. Strategic partnerships and innovative treatment modalities further enhance market opportunities.
Market Outlook: The market stood at USD 1.1 billion in 2024 and is projected to reach USD 2.4 billion by 2034, growing at a 7.0% CAGR.